16-10-2020
pirke / Shutterstock.com
A medical device company, St. Jude Medical, part of Abbott Laboratories, failed in its bid to invalidate a patent for an artificial heart valve at the US Court of Appeals for the Federal Circuit yesterday, Thursday, October 15.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
Federal Circuit, Snyders Heart Valve, patent, St. Jude Medical, US Court for the Eastern District of Texas, prior art, obviousness, USPTO, PTAB
Federal Circuit hands victory to Snyders over heart valve patent
07-10-2021
Snyders revives patent claims against St Jude Medical
25-03-2021
Philips sues Boston Scientific over cardiac diagnostic patents
03-11-2020
Abbott sues ex-employee over COVID-19 tests
21-10-2020
Boston Scientific and Edwards settle heart valve disputes
15-01-2019
Medtronic seeks to settle patent dispute with Snyder
16-05-2017
